{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T18:18:37Z","timestamp":1776536317100,"version":"3.51.2"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T00:00:00Z","timestamp":1632096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T00:00:00Z","timestamp":1632096000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82060577"],"award-info":[{"award-number":["82060577"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81760566"],"award-info":[{"award-number":["81760566"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The role of postoperative radiotherapy (PORT) in cardiovascular-pulmonary disease mortality in patients with stage IIIA-N2 resected non-small cell lung cancer (NSCLC) remains uncertain. The purpose of this population-based analysis was to explore the effect of PORT on cardiovascular-pulmonary disease mortality in these patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Patients aged\u2009\u2265\u200918 years with stage IIIA-N2 resected NSCLC were identified in the Surveillance, Epidemiology, and End Results (SEER) database from 2004 to 2015 and were grouped according to the use of PORT. Propensity score matching (PSM) was used to account for differences in baseline characteristics between the Non-PORT and PORT groups. The cumulative risk for cardiovascular-pulmonary disease death was estimated using the cumulative incidence curve. Competing risk regression was used to run univariate and multivariate analyses to evaluate risk factors.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 3981 patients were included in the study population. Among them, 1446 patients received PORT, and 2535 did not. A total of 1380 patients remained in each group after PSM, and the baseline characteristics were not significantly different between the two groups. The cumulative incidence of cardiovascular-pulmonary mortality was 10.93% in the Non-PORT group compared with 9.85% in the PORT group. There was no significant difference in the cumulative risk between the two groups (HR 1.07, 95% CI 0.77\u20131.48, <jats:italic>p<\/jats:italic>\u2009=\u20090.703). Multivariate analysis indicated that PORT had no significant impact on increased risk, with an HR of 1.18 (<jats:italic>p<\/jats:italic>\u2009=\u20090.377).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>No significant differences between the PORT and Non-PORT groups were found in cardiovascular-pulmonary-specific modalities in this study. Further studies are required to validate these results. This study highlights the importance of long-term surveillance for NSCLC patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13014-021-01912-4","type":"journal-article","created":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T14:07:02Z","timestamp":1632146822000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Effects of postoperative radiotherapy on cardiovascular-pulmonary disease mortality in patients with stage IIIA-N2 resected NSCLC: analysis of the SEER database"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6986-0979","authenticated-orcid":false,"given":"Xia","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaqi","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhimin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anwen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,20]]},"reference":[{"issue":"3","key":"1912_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"Cancer J Clin"},{"issue":"Suppl 4","key":"1912_CR2","doi-asserted-by":"publisher","first-page":"iv192","DOI":"10.1093\/annonc\/mdy275","volume":"29","author":"D Planchard","year":"2018","unstructured":"Planchard D, Popat S, Kerr K, Novello S, Smit EF, Faivre-Finn C, Mok TS, Reck M, Van Schil PE, Hellmann MD, et al. Metastatic non-small cell lung cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol Off J Eur Soc Med Oncol. 2018;29(Suppl 4):iv192-237.","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"issue":"1","key":"1912_CR3","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1093\/ejcts\/ezx274","volume":"53","author":"AS Bugge","year":"2018","unstructured":"Bugge AS, Lund MB, Valberg M, Brustugun OT, Solberg S, Kongerud J. Cause-specific death after surgical resection for early-stage non-small-cell lung cancer. Eur J Cardio-thoracic Surg Off J Eur Assoc Cardio-thoracic Surg. 2018;53(1):221\u20137.","journal-title":"Eur J Cardio-thoracic Surg Off J Eur Assoc Cardio-thoracic Surg"},{"key":"1912_CR4","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3389\/fonc.2020.00362","volume":"10","author":"YH Zhang","year":"2020","unstructured":"Zhang YH, Lu Y, Lu H, Zhou YM. Development of a survival prognostic model for non-small cell lung cancer. Front Oncol. 2020;10:362.","journal-title":"Front Oncol"},{"issue":"6","key":"1912_CR5","doi-asserted-by":"publisher","first-page":"718","DOI":"10.6004\/jnccn.2020.7537","volume":"18","author":"F Gao","year":"2020","unstructured":"Gao F, Li N, Xu Y, Yang G. Effects of postoperative radiotherapy on survival of patients with stage IIIA resected non-small cell lung cancer: analysis of the SEER database. J Natl Comp Cancer Netw. 2020;18(6):718\u201327.","journal-title":"J Natl Comp Cancer Netw"},{"key":"1912_CR6","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ijcard.2021.02.025","volume":"330","author":"JY Sun","year":"2021","unstructured":"Sun JY, Zhang ZY, Qu Q, Wang N, Zhang YM, Miao LF, Wang J, Wu LD, Liu Y, Zhang CY, et al. Cardiovascular disease-specific mortality in 270,618 patients with non-small cell lung cancer. Int J Cardiol. 2021;330:186\u201393.","journal-title":"Int J Cardiol"},{"issue":"11","key":"1912_CR7","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/S1470-2045(20)30453-8","volume":"21","author":"M Provencio","year":"2020","unstructured":"Provencio M, Nadal E, Insa A, Garc\u00eda-Campelo MR, Casal-Rubio J, D\u00f3mine M, Majem M, Rodr\u00edguez-Abreu D, Mart\u00ednez-Mart\u00ed A, De Castro Carpe\u00f1o J, et al. Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre, single-arm, phase 2 trial. Lancet Oncol. 2020;21(11):1413\u201322.","journal-title":"Lancet Oncol"},{"issue":"25","key":"1912_CR8","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.1200\/JCO.2017.72.4401","volume":"35","author":"MG Kris","year":"2017","unstructured":"Kris MG, Gaspar LE, Chaft JE, Kennedy EB, Azzoli CG, Ellis PM, Lin SH, Pass HI, Seth R, Shepherd FA, et al. Adjuvant systemic therapy and adjuvant radiation therapy for stage I to IIIA completely resected non-small-cell lung cancers: American Society of Clinical Oncology\/Cancer Care Ontario Clinical Practice Guideline Update. J Clin Oncol Off J Am Soc Clin Oncol. 2017;35(25):2960\u201374.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"31","key":"1912_CR9","first-page":"S1178","volume":"2020","author":"CPN Le Pechoux","year":"2020","unstructured":"Le Pechoux CPN, Barlesi F, Faivre-Finn C, Lerouge D, Zalcman G, et al. An international randomized trial, comparing post-operative conformal radiotherapy (PORT) to no PORT, in patients with completely resected non-small cell lung cancer (NSCLC) and mediastinal N2 involvement: primary end-point analysis of LungART (IFCT-0503, UK NCRI, SAKK) NCT00410683. Eur Soc Med Oncol Virtual Congress. 2020;2020(31):S1178.","journal-title":"Eur Soc Med Oncol Virtual Congress"},{"issue":"8","key":"1912_CR10","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1200\/JCO.2014.58.5380","volume":"33","author":"CG Robinson","year":"2015","unstructured":"Robinson CG, Patel AP, Bradley JD, DeWees T, Waqar SN, Morgensztern D, Baggstrom MQ, Govindan R, Bell JM, Guthrie TJ, et al. Postoperative radiotherapy for pathologic N2 non-small-cell lung cancer treated with adjuvant chemotherapy: a review of the National Cancer Data Base. J Clin Oncol Off J Am Soc Clin Oncol. 2015;33(8):870\u20136.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"9722","key":"1912_CR11","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/S0140-6736(10)60059-1","volume":"375","author":"R Arriagada","year":"2010","unstructured":"Arriagada R, Auperin A, Burdett S, Higgins JP, Johnson DH, Le Chevalier T, Le Pechoux C, Parmar MK, Pignon JP, Souhami RL, et al. Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data. Lancet. 2010;375(9722):1267\u201377.","journal-title":"Lancet"},{"key":"1912_CR12","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1001\/jamaoncol.2021.1910","volume":"7","author":"Z Hui","year":"2021","unstructured":"Hui Z, Men Y, Hu C, Kang J, Sun X, Bi N, Zhou Z, Liang J, Lv J, Feng Q, et al. Effect of postoperative radiotherapy for patients with pIIIA-N2 non-small cell lung cancer after complete resection and adjuvant chemotherapy: the phase 3 PORT-C randomized clinical trial. JAMA Oncol. 2021;7:1178\u201385.","journal-title":"JAMA Oncol."},{"key":"1912_CR13","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1186\/s12885-015-1326-6","volume":"15","author":"W Feng","year":"2015","unstructured":"Feng W, Zhang Q, Fu XL, Cai XW, Zhu ZF, Yang HJ, Xiang JQ, Zhang YW, Chen HQ. The emerging outcome of postoperative radiotherapy for stage IIIA(N2) non-small cell lung cancer patients: based on the three-dimensional conformal radiotherapy technique and institutional standard clinical target volume. BMC Cancer. 2015;15:348.","journal-title":"BMC Cancer"},{"issue":"1","key":"1912_CR14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.radonc.2013.08.011","volume":"110","author":"C Billiet","year":"2014","unstructured":"Billiet C, Decaluw\u00e9 H, Peeters S, Vansteenkiste J, Dooms C, Haustermans K, De Leyn P, De Ruysscher D. Modern post-operative radiotherapy for stage III non-small cell lung cancer may improve local control and survival: a meta-analysis. Radiother Oncol J Eur Soc Therap Radiol Oncol. 2014;110(1):3\u20138.","journal-title":"Radiother Oncol J Eur Soc Therap Radiol Oncol"},{"issue":"3","key":"1912_CR15","first-page":"462","volume":"10","author":"JL Mikell","year":"2015","unstructured":"Mikell JL, Gillespie TW, Hall WA, Nickleach DC, Liu Y, Lipscomb J, Ramalingam SS, Rajpara RS, Force SD, Fernandez FG, et al. Postoperative radiotherapy is associated with better survival in non-small cell lung cancer with involved N2 lymph nodes: results of an analysis of the National Cancer Data Base. J Thoracic Oncol Off Publ Int Assoc Study Lung Cancer. 2015;10(3):462\u201371.","journal-title":"J Thoracic Oncol Off Publ Int Assoc Study Lung Cancer"},{"issue":"12","key":"1912_CR16","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s11883-019-0810-x","volume":"21","author":"R da Silva","year":"2019","unstructured":"da Silva R. Effects of radiotherapy in coronary artery disease. Curr Atheroscler Rep. 2019;21(12):50.","journal-title":"Curr Atheroscler Rep"},{"issue":"4","key":"1912_CR17","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.currproblcancer.2018.05.008","volume":"42","author":"MA Armanious","year":"2018","unstructured":"Armanious MA, Mohammadi H, Khodor S, Oliver DE, Johnstone PA, Fradley MG. Cardiovascular effects of radiation therapy. Curr Probl Cancer. 2018;42(4):433\u201342.","journal-title":"Curr Probl Cancer"},{"issue":"6","key":"1912_CR18","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/j.pcl.2020.07.007","volume":"67","author":"H Visscher","year":"2020","unstructured":"Visscher H, Otth M, Feijen E, Nathan PC, Kuehni CE. Cardiovascular and pulmonary challenges after treatment of childhood cancer. Pediatric Clin North Am. 2020;67(6):1155\u201370.","journal-title":"Pediatric Clin North Am"},{"issue":"1","key":"1912_CR19","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.chest.2019.03.033","volume":"156","author":"AN Hanania","year":"2019","unstructured":"Hanania AN, Mainwaring W, Ghebre YT, Hanania NA, Ludwig M. Radiation-induced lung injury: assessment and management. Chest. 2019;156(1):150\u201362.","journal-title":"Chest"},{"issue":"9","key":"1912_CR20","doi-asserted-by":"publisher","first-page":"e015022","DOI":"10.1136\/bmjopen-2016-015022","volume":"7","author":"SK Hung","year":"2017","unstructured":"Hung SK, Chen YC, Chiou WY, Lai CL, Lee MS, Lo YC, Chen LC, Huang LW, Chien NC, Li SC, et al. Irradiation enhanced risks of hospitalised pneumonopathy in lung cancer patients: a population-based surgical cohort study. BMJ Open. 2017;7(9):e015022.","journal-title":"BMJ Open"},{"issue":"2","key":"1912_CR21","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/clc.22631","volume":"40","author":"P Sardar","year":"2017","unstructured":"Sardar P, Kundu A, Chatterjee S, Nohria A, Nairooz R, Bangalore S, Mukherjee D, Aronow WS, Lavie CJ. Long-term cardiovascular mortality after radiotherapy for breast cancer: a systematic review and meta-analysis. Clin Cardiol. 2017;40(2):73\u201381.","journal-title":"Clin Cardiol"},{"issue":"8","key":"1912_CR22","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/S1470-2045(05)70251-5","volume":"6","author":"SC Darby","year":"2005","unstructured":"Darby SC, McGale P, Taylor CW, Peto R. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol. 2005;6(8):557\u201365.","journal-title":"Lancet Oncol"},{"issue":"16","key":"1912_CR23","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1182\/blood-2016-09-740332","volume":"129","author":"FA van Nimwegen","year":"2017","unstructured":"van Nimwegen FA, Ntentas G, Darby SC, Schaapveld M, Hauptmann M, Lugtenburg PJ, Janus CPM, Daniels L, van Leeuwen FE, Cutter DJ, et al. Risk of heart failure in survivors of Hodgkin lymphoma: effects of cardiac exposure to radiation and anthracyclines. Blood. 2017;129(16):2257\u201365.","journal-title":"Blood"},{"issue":"6","key":"1912_CR24","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1001\/jamainternmed.2015.1180","volume":"175","author":"FA van Nimwegen","year":"2015","unstructured":"van Nimwegen FA, Schaapveld M, Janus CP, Krol AD, Petersen EJ, Raemaekers JM, Kok WE, Aleman BM, van Leeuwen FE. Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk. JAMA Int Med. 2015;175(6):1007\u201317.","journal-title":"JAMA Int Med"},{"issue":"6","key":"1912_CR25","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1002\/cncr.29857","volume":"122","author":"SH Lin","year":"2016","unstructured":"Lin SH, Zhang N, Godby J, Wang J, Marsh GD, Liao Z, Komaki R, Ho L, Hofstetter WL, Swisher SG, et al. Radiation modality use and cardiopulmonary mortality risk in elderly patients with esophageal cancer. Cancer. 2016;122(6):917\u201328.","journal-title":"Cancer"},{"issue":"48","key":"1912_CR26","doi-asserted-by":"publisher","first-page":"3889","DOI":"10.1093\/eurheartj\/ehz766","volume":"40","author":"KM Sturgeon","year":"2019","unstructured":"Sturgeon KM, Deng L, Bluethmann SM, Zhou S, Trifiletti DM, Jiang C, Kelly SP, Zaorsky NG. A population-based study of cardiovascular disease mortality risk in US cancer patients. Eur Heart J. 2019;40(48):3889\u201397.","journal-title":"Eur Heart J"},{"key":"1912_CR27","doi-asserted-by":"crossref","unstructured":"Fine J, Gray R, Jason P. A proportional hazards model for the subdistribution of competing risks in survival analysis. 1999.","DOI":"10.1080\/01621459.1999.10474144"},{"issue":"4","key":"1912_CR28","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.ijrobp.2008.11.016","volume":"73","author":"S Demirci","year":"2009","unstructured":"Demirci S, Nam J, Hubbs JL, Nguyen T, Marks LB. Radiation-induced cardiac toxicity after therapy for breast cancer: interaction between treatment era and follow-up duration. Int J Radiat Oncol Biol Phys. 2009;73(4):980\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"1912_CR29","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa1209825","volume":"368","author":"SC Darby","year":"2013","unstructured":"Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Br\u00f8nnum D, Correa C, Cutter D, Gagliardi G, Gigante B, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013;368(11):987\u201398.","journal-title":"N Engl J Med"},{"issue":"1","key":"1912_CR30","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1200\/JCO.2016.69.1378","volume":"35","author":"SG Chun","year":"2017","unstructured":"Chun SG, Hu C, Choy H, Komaki RU, Timmerman RD, Schild SE, Bogart JA, Dobelbower MC, Bosch W, Galvin JM, et al. Impact of intensity-modulated radiation therapy technique for locally advanced non-small-cell lung cancer: a secondary analysis of the NRG oncology RTOG 0617 randomized clinical trial. J Clin Oncol Off J Am Soc Clin Oncol. 2017;35(1):56\u201362.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"1","key":"1912_CR31","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cllc.2015.07.006","volume":"17","author":"DC Ling","year":"2016","unstructured":"Ling DC, Hess CB, Chen AM, Daly ME. Comparison of toxicity between intensity-modulated radiotherapy and 3-dimensional conformal radiotherapy for locally advanced non-small-cell lung cancer. Clin Lung Cancer. 2016;17(1):18\u201323.","journal-title":"Clin Lung Cancer"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-021-01912-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-021-01912-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-021-01912-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T14:14:40Z","timestamp":1632147280000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-021-01912-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,20]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1912"],"URL":"https:\/\/doi.org\/10.1186\/s13014-021-01912-4","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,20]]},"assertion":[{"value":"11 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was based on public use data from the SEER database. The study did not require informed consent from the SEER registered cases, and the authors obtained Limited-Use Data Agreements from SEER.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"184"}}